An Educational Forum comparing the Asthma Control Test (ACT) and the Asthma Impairment and Risk Questionnaire (AIRQ)
Join us for a free webinar with Mimi Guiracocha, DNP, RN and Alexander Mackie, PHD, discussing two of the most prevalent Asthma-related evaluations: the Asthma Control Test, or ACT, and the Asthma Impairment and Risk Questionnaire, or AIRQ.
Mimi's presentation will cover why assessing asthma control matters and how it is different from measuring/assigning asthma severity, as well as covering how to assess asthma control using one of several validated tools: the Asthma Control Test (ACT).
Alex’s presentation will provide a brief overview of a new asthma assessment tool called the AirQ. This easy to use, 10 question, free validated tool incorporates both impairment and risk components of asthma and has been shown to be predictive of future asthma exacerbations. Additionally, resources are available to assist with incorporation of the tool into several EMR systems.
This event is FREE to attend for all, but registration is required to receive the Zoom link!
Presenters:
Mimi Guiracocha, DNP, RN
Mimi Guiracocha, DNP, RN, is is a public health nurse working for the American Lung Association as Manager of Health Promotions. There, she plays a critical role in the coordination of mission activities, including lung health education, health promotion, and advocacy. Prior to this position, Dr. Guiracocha worked as a NICU nurse, advocating for all families to have equitable access to quality care. She has also worked with the Chicago Public Schools to improve school management of chronic conditions for students. Dr. Guiracocha holds her B.S. from Wheaton College in Illinois, B.S.N. from Loyola University Chicago, and her doctoral degree from Rush University in Advanced Public Health Nursing. Dr. Guiracocha is Ecuadorian-American, a life-long resident of Chicago, passionate about environmental justice and community organizing, and speaks Spanish.
Alex Mackie, PhD
Alex Mackie originally hails from Toronto, Ontario, Canada and attended McMaster University for his undergraduate studies. He obtained his PhD in Pharmacology from Loyola University Chicago and completed post-doctoral trainings at Northwestern University prior to becoming a research faculty member at the same institution. His career transitioned to Industry in 2016 as a Medical Science Liaison and has been a Senior Respiratory MSL with AstraZeneca for the past 5 years supporting therapies and clinical trial programs within the asthma and COPD disease states.
